Based on these emulations, we estimate an average treatment effect at 48 months for SGLT2i compared to DPP4i of 6.9% (CI95: 9.9% - 3.4%)
doi: 10.1161/STR.0000000000000475 [DOI] [PubMed] [Google Scholar] 40.ElSayed NA, Aleppo G, Aroda VR, et al
However, when compared to insulin, GLP-1 RAs provided protection against advanced-stage DR
As a glucagon-like peptide-1 (GLP-1) receptor agonist, it plays a vital role in controlling blood sugar levels
Nevertheless, it behooves us to recall that the effectiveness of allosteric sites is determines by both stable interactions at the site, which is something that AI can help with, and initiation of effective allosteric signals, which would be more challenging
FFS, the five-factor score